Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 13, Number 29, 2007

Articles

Favourites:
ADD

Interactive Endogenous Small Molecule (Gaseous) Signaling: Implications for Teratogenesis
pp. 2952-2978(27)
Authors: Fukuto, Jon M.; Collins, Michael D.

Favourites:
ADD

New Proposals for Testing Drugs with IKr-Blocking Activity to Determine Their Teratogenic Potential
pp. 2979-2988(10)
Authors: Karlsson, Miriam; Danielsson, Bengt R.; Nilsson, Mats F.; Danielsson, Christian; Webster, William S.

Favourites:
ADD

The Effects of the Endocrine Disruptors Dithiocarbamates on the Mammalian Ovary with Particular Regard to Mancozeb
pp. 2989-3004(16)
Authors: Cecconi, Sandra; Paro, Rita; Rossi, Gianna; Macchiarelli, Guido

Favourites:
ADD

Reproductive Toxicology of Environmental Toxicants: Emerging Issues and Concerns
pp. 3005-3019(15)
Authors: Younglai, E. V.; Wu, Y. J .; Foster, W. G.

Favourites:
ADD
Favourites:
ADD

Multiligand Endocytosis and Congenital Defects: Roles of Cubilin, Megalin and Amnionless
pp. 3038-3046(9)
Authors: Kozyraki, Renata; Gofflot, Francoise

Favourites:
ADD

The Development of New Concepts for Assessing Reproductive Toxicity Applicable to Large Scale Toxicological Programmes
pp. 3047-3058(12)
Authors: Bremer, S.; Pellizzer, C.; Hoffmann, S.; Seidle, T.; Hartung, T.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content